CSIMarket


Mesoblast Ltd  (MESO)
Other Ticker:  
 

Mesoblast Ltd

MESO's Fundamental analysis








Mesoblast Ltd's sales fell by -26.56 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 3535

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -12.88 %

Mesoblast Ltd net loss deacreased by in IV. Quarter 2023 year on year, Mesoblast Ltd net loss increased by -10.35 % in IV. Quarter 2023 year on year,

More on MESO's Growth


Mesoblast Ltd
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 48.05 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 387.22.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.64.


More on MESO's Valuation
 
 Total Debt (Millions $) 103
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.68

Mesoblast Ltd
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 48.05 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 387.22.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.64.

Mesoblast Ltd Price to Book Ratio is at 5.79 lower than Indusry Avg. of 827.85. and higher than S&P 500 Avg. of 0.01

More on MESO's Valuation

  Market Capitalization (Millions $) 2,905
  Shares Outstanding (Millions) 739
  Employees -
  Revenues (TTM) (Millions $) 8
  Net Income (TTM) (Millions $) -82
  Cash Flow (TTM) (Millions $) 60
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) 103
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 0.68

  Market Capitalization (Millions $) 2,905
  Shares Outstanding (Millions) 739
  Employees -
  Revenues (TTM) (Millions $) 8
  Net Income (TTM) (Millions $) -82
  Cash Flow (TTM) (Millions $) 60
  Capital Exp. (TTM) (Millions $) -


    MESO's Profitability Comparisons
Mesoblast Ltd